-
Retirement Simplified
-
Calculators
Knowledge Centre
- Public Provident Fund
- NPS Reforms 2025
- EPF Rule Changes
- NPS vs Mutual Funds
- Multiple Scheme Framework (MSF)
- Wealth Creation and Legacy Planning
- Retirement Planning Under the Old & New Tax Regime
- Why Thinking Beyond FDs Is Important
- Retirement Corpus Planning
- Portfolio Diversification
- Senior Citizen Community Living in India
- View All
Who we are
DSP Healthcare Fund Direct-growth
Latest AUM
₹ 2,891.8 Cr.
NAV as on 21 apr, 2026
₹ 41.96
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 21 apr, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Cipla Ltd | Healthcare | Equity | 9.16% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.85% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.85% |
| Cipla Ltd | Healthcare | Equity | 8.63% |
| Cipla Ltd | Healthcare | Equity | 8.63% |
| Ipca Laboratories Ltd | Healthcare | Equity | 9.39% |
| Cipla Ltd | Healthcare | Equity | 8.69% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.33% |
| Cipla Ltd | Healthcare | Equity | 8.76% |
| Cipla Ltd | Healthcare | Equity | 8.55% |
Debt & Credit Risk Analysis
| Alpha | -0.02% |
| Beta | 0.84% |
| Sharpe Ratio | 0.98% |
| Standard Deviation | 15.10% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 0.42% | NA | 6.12% |
| 6 Months | -4.27% | NA | 12.92% |
| 9 Months | -4.93% | NA | 4.47% |
| 1 Year | 1.96% | 1.96% | 6.04% |
| 2 Years | 20.96% | 9.98% | 24.93% |
| 3 Years | 81.63% | 22.01% | 25.71% |
| 5 Years | 95.17% | 14.31% | 19.91% |
| 7 Years | 301.58% | 21.97% | NA |
Historical NAV
| Date | NAV |
|---|---|
| 21 Apr 2026 | ₹41.96 |
| 20 Apr 2026 | ₹42.20 |
| 17 Apr 2026 | ₹42.47 |
| 16 Apr 2026 | ₹41.89 |
| 15 Apr 2026 | ₹42.01 |
| 13 Apr 2026 | ₹41.33 |
| 10 Apr 2026 | ₹41.17 |
| 09 Apr 2026 | ₹40.94 |
| 08 Apr 2026 | ₹40.92 |
| 07 Apr 2026 | ₹40.28 |
| 06 Apr 2026 | ₹40.11 |
| 02 Apr 2026 | ₹40.11 |
| 01 Apr 2026 | ₹40.46 |
| 31 Mar 2026 | ₹40.27 |
| 30 Mar 2026 | ₹40.07 |
| 27 Mar 2026 | ₹40.43 |
| 25 Mar 2026 | ₹41.04 |
| 24 Mar 2026 | ₹40.32 |
| 23 Mar 2026 | ₹39.92 |
| 20 Mar 2026 | ₹40.56 |
| 19 Mar 2026 | ₹40.21 |
| 18 Mar 2026 | ₹40.85 |
| 17 Mar 2026 | ₹40.69 |
| 16 Mar 2026 | ₹40.44 |
| 13 Mar 2026 | ₹40.58 |
| 12 Mar 2026 | ₹41.10 |
| 11 Mar 2026 | ₹41.39 |
| 10 Mar 2026 | ₹41.39 |
| 09 Mar 2026 | ₹41.28 |
| 06 Mar 2026 | ₹41.22 |
Portfolio Updated on: 22 Apr, 2026
Fund Growth & Size Analysis
Compare Mutual funds
DSP Healthcare Fund Direct-growth Returns Comparison
Compare DSP Healthcare Fund Direct-growth with any MF,
EYF, stock or index
No funds found for your search.
DSP Healthcare Fund Direct-growth is one Equity mutual fund offered by DSP Mutual Fund. Launched on 30 Nov 2018, the fund aims Long term capital growth. Investment in equity and equity related Securities of healthcare and pharmaceutical companies. It manages assets worth ₹2,891.8 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.62%.
Chirag Dagli has experience Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
As of Tue Mar 31, 2026, the total assets managed under DSP Healthcare Fund Direct-growth stand at approximately ₹ 2,891.8 crore.
The DSP Healthcare Fund Direct-growth has delivered the following short-term performance:
- 3 Months Return: 0.42%
The historical growth of the DSP Healthcare Fund Direct-growth is reflected through its CAGR returns:
- 3 Year CAGR: 22.01%
- 5 Year CAGR: 14.31%
- Return Since Launch: 21.40%
The portfolio of DSP Healthcare Fund Direct-growth is distributed across different asset classes as follows:
- Equity: 98.54%
- Other Assets: 1.46%
The DSP Healthcare Fund Direct-growth is managed by Chirag Dagli, representing DSP Mutual Fund.
The DSP Healthcare Fund Direct-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 33.20%
- Mid Cap Stocks: 26.02%
- Small Cap Stocks: 40.79%
Top stock holdings of DSP Healthcare Fund Direct-growth include:
- Cipla Ltd – represents 9.16% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.85% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.85% of the portfolio
- Cipla Ltd – represents 8.63% of the portfolio
- Cipla Ltd – represents 8.63% of the portfolio
- Ipca Laboratories Ltd – represents 9.39% of the portfolio
- Cipla Ltd – represents 8.69% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.33% of the portfolio
- Cipla Ltd – represents 8.76% of the portfolio
- Cipla Ltd – represents 8.55% of the portfolio
Major sector exposures in DSP Healthcare Fund Direct-growth are:
- Healthcare – accounts for 171.90% of the portfolio
